← Scroll for more →
Financial Statements — SLN
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 72.05 | 5.66 | 11.28 | 82.03 | 41.74 | 64.89 | 121.33 | 54.03 | 54.82 | 73.54 |
| Short-term Investments | 0.00 | 64.42 | 73.84 | 20.16 | 72.42 | 71.65 | 26.00 | -- | -- | -- |
| Accounts Receivable | -- | 0.00 | 0.00 | 0.03 | 0.09 | 0.04 | 0.97 | -- | -- | -- |
| Total Current Assets | 94.28 | 102.85 | 118.66 | 133.63 | 148.55 | 169.79 | 187.37 | 81.02 | 96.69 | 86.33 |
| Property, Plant & Equipment | 1.33 | 1.40 | 1.58 | 1.66 | 1.78 | 1.69 | 1.82 | -- | -- | -- |
| Goodwill | 10.33 | 10.36 | 10.62 | 10.61 | 10.62 | 9.78 | 9.39 | -- | -- | -- |
| Intangible Assets | -- | -- | 0.29 | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets | 12.13 | 12.27 | 12.78 | 13.16 | 16.68 | 15.51 | 15.27 | 12.80 | 10.81 | 9.86 |
| Total Assets | 106.41 | 115.12 | 131.44 | 146.79 | 165.23 | 185.30 | 202.64 | -- | -- | -- |
| Total Current Liabilities | 12.71 | 10.46 | 13.61 | 17.38 | 14.77 | 19.26 | 16.82 | 17.77 | 21.94 | 15.17 |
| Total Non-current Liabilities* | 55.23 | 55.26 | 55.53 | 55.35 | 56.31 | 53.29 | 51.79 | 59.00 | 63.49 | 72.50 |
| Total Liabilities | 67.94 | 65.72 | 69.14 | 72.73 | 71.08 | 72.56 | 68.61 | -- | -- | -- |
| Retained Earnings | (589.63) | (577.53) | (562.57) | (550.80) | (529.84) | (502.54) | (474.04) | (304.61) | (263.26) | (222.97) |
| Total Stockholder Equity | 38.47 | 49.40 | 62.30 | 74.06 | 94.16 | 112.74 | 134.02 | 17.05 | 22.07 | 8.53 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.42 | 0.03 | 0.16 | 0.22 | 0.14 | 25.31 |
| Cost of Revenue | 0.00 | 0.01 | 0.01 | 0.06 | 0.09 | 0.05 | 2.04 |
| Gross Profit | 0.00 | 0.41 | 0.02 | 0.10 | 0.14 | 0.09 | 23.27 |
| Research & Development | 9.15 | 9.12 | 8.75 | 20.54 | 17.65 | 20.81 | 22.08 |
| Selling, General & Admin | 4.72 | 7.03 | 3.73 | 5.80 | 5.13 | 7.68 | 5.54 |
| Total Operating Expenses* | 13.87 | 16.15 | 12.48 | 26.34 | 24.10 | 28.50 | 27.62 |
| Operating Income | (13.86) | (15.74) | (12.46) | (26.24) | (23.96) | (28.41) | (4.35) |
| Pretax Income | (12.27) | (14.96) | (11.77) | (20.96) | (27.34) | (28.53) | 12.63 |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.32 |
| Net Income | (12.27) | (14.96) | (11.77) | (20.96) | (27.35) | (28.53) | 12.30 |
| Basic EPS | (0.09) | (0.11) | (0.09) | (0.15) | (0.19) | (0.20) | 0.08 |
| Diluted EPS | (0.09) | (0.11) | (0.09) | (0.15) | (0.19) | (0.20) | 0.08 |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.52 | (15.60) | (17.29) | (10.89) | (21.78) | (12.31) |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 |
| Free Cash Flow* | 1.52 | (15.60) | (17.29) | (10.89) | (21.83) | (12.31) |
| Investing Cash Flow | 64.94 | 10.00 | (53.34) | 51.29 | (1.56) | (44.38) |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
← Scroll for more columns →
* Derived from reported values